Literature DB >> 33119971

Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis.

Klára Gotvaldová1, Kateřina Hájková1,2, Jan Borovička3,4, Radek Jurok1,2,5, Petra Cihlářová1,2, Martin Kuchař1,6.   

Abstract

Psilocybin, psilocin, baeocystin, norbaeocystin, and aeruginascin are tryptamines structurally similar to the neurotransmitter serotonin. Psilocybin and its pharmacologically active metabolite psilocin in particular are known for their psychoactive effects. These substances typically occur in most species of the genus Psilocybe (Fungi, Strophariaceae). Even the sclerotia of some of these fungi known as "magic truffles" are of growing interest in microdosing due to them improving cognitive function studies. In addition to microdosing studies, psilocybin has also been applied in clinical studies, but only its pure form has been administrated so far. Moreover, the determination of tryptamine alkaloids is used in forensic analysis. In this study, freshly cultivated fruit bodies of Psilocybe cubensis were used for monitoring stability (including storage and processing conditions of fruiting bodies). Furthermore, mycelium and the individual parts of the fruiting bodies (caps, stipes, and basidiospores) were also examined. The concentration of tryptamines in final extracts was analyzed using ultra-high-performance liquid chromatography coupled with mass spectrometry. No tryptamines were detected in the basidiospores, and only psilocin was present at 0.47 wt.% in the mycelium. The stipes contained approximately half the amount of tryptamine alkaloids (0.52 wt.%) than the caps (1.03 wt.%); however, these results were not statistically significant, as the concentration of tryptamines in individual fruiting bodies is highly variable. The storage conditions showed that the highest degradation of tryptamines was seen in fresh mushrooms stored at -80°C, and the lowest decay was seen in dried biomass stored in the dark at room temperature.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS; mushrooms; psilocybin; stability; tryptamines

Year:  2020        PMID: 33119971     DOI: 10.1002/dta.2950

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  8 in total

1.  Natural language signatures of psilocybin microdosing.

Authors:  Camila Sanz; Federico Cavanna; Stephanie Muller; Laura de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar; Facundo Carrillo; Adolfo M García; Carla Pallavicini; Enzo Tagliazucchi
Journal:  Psychopharmacology (Berl)       Date:  2022-06-09       Impact factor: 4.415

2.  Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis).

Authors:  Curro Polo-Castellano; José Á Álvarez; Miguel Palma; Gerardo F Barbero; Jesús Ayuso; Marta Ferreiro-González
Journal:  J Fungi (Basel)       Date:  2022-06-02

3.  Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.

Authors:  Carla Pallavicini; Enzo Tagliazucchi; Federico Cavanna; Stephanie Muller; Laura Alethia de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar
Journal:  Transl Psychiatry       Date:  2022-08-02       Impact factor: 7.989

4.  Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.

Authors:  Grant C Glatfelter; Duyen N K Pham; Donna Walther; James A Golen; Andrew R Chadeayne; Michael H Baumann; David R Manke
Journal:  ACS Omega       Date:  2022-07-05

5.  Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.

Authors:  Sen Yao; Chuanzheng Wei; Hui Lin; Peng Zhang; Yuanyuan Liu; Youjin Deng; Qianhui Huang; Baogui Xie
Journal:  J Fungi (Basel)       Date:  2022-08-18

6.  Genetic Survey of Psilocybe Natural Products.

Authors:  Sebastian Dörner; Kai Rogge; Janis Fricke; Tim Schäfer; Jacob M Wurlitzer; Markus Gressler; Duyen N K Pham; David R Manke; Andrew R Chadeayne; Dirk Hoffmeister
Journal:  Chembiochem       Date:  2022-06-09       Impact factor: 3.461

Review 7.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 8.  Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.

Authors:  Shawn Ziff; Benjamin Stern; Gregory Lewis; Maliha Majeed; Vasavi Rakesh Gorantla
Journal:  Cureus       Date:  2022-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.